Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Brott

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Seminars in Vascular Surgery|March 23, 2026
CREST-2: Early reflections on the primary resultsJames F Meschia, Brajesh Lal, Thomas Brott
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 19, 2008
Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomographyChristopher Nichols, Jane Khoury, Thomas Brott, et al.
Transfusion|June 1, 2006
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profileJerrold H Levy, Abe Fingerhut, Thomas Brott, et al.
Stroke|June 24, 2006
Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhageEdward C Jauch, Christopher J Lindsell, Opeolu Adeoye, et al.
Annals of Emergency Medicine|March 30, 2005
The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke StudyThomas Kwiatkowski, Richard Libman, Barbara C Tilley, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 20, 2021
Non-Adherence to Antihypertensive Guidelines in Patients with Asymptomatic Carotid StenosisWilliam Haley, Fayaz Shawl, W Charles Sternbergh, et al.
Stroke|May 24, 2003
Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiableJoseph P Broderick, Catherine M Viscoli, Thomas Brott, et al.
Stroke|August 6, 2005
Major risk factors for intracerebral hemorrhage in the young are modifiableEdward Feldmann, Joseph P Broderick, Walter N Kernan, et al.
The Neurohospitalist|July 7, 2018
Transatlantic Differences in Management of Carotid Stenosis: BRIDGing the Gap in StrokE Management (BRIDGE) ProjectClotilde Balucani, Vanessa Arnedo, Jeremy Weedon, et al.
JACC. Cardiovascular Interventions|October 25, 2014
Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot studyJosep Rodés-Cabau, Philip Kahlert, Franz-Josef Neumann, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Seminars in Vascular Surgery|March 23, 2026
CREST-2: Early reflections on the primary resultsJames F Meschia, Brajesh Lal, Thomas Brott
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 19, 2008
Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomographyChristopher Nichols, Jane Khoury, Thomas Brott, et al.
Transfusion|June 1, 2006
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profileJerrold H Levy, Abe Fingerhut, Thomas Brott, et al.
Stroke|June 24, 2006
Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhageEdward C Jauch, Christopher J Lindsell, Opeolu Adeoye, et al.
Annals of Emergency Medicine|March 30, 2005
The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke StudyThomas Kwiatkowski, Richard Libman, Barbara C Tilley, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 20, 2021
Non-Adherence to Antihypertensive Guidelines in Patients with Asymptomatic Carotid StenosisWilliam Haley, Fayaz Shawl, W Charles Sternbergh, et al.
Stroke|May 24, 2003
Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiableJoseph P Broderick, Catherine M Viscoli, Thomas Brott, et al.
Stroke|August 6, 2005
Major risk factors for intracerebral hemorrhage in the young are modifiableEdward Feldmann, Joseph P Broderick, Walter N Kernan, et al.
The Neurohospitalist|July 7, 2018
Transatlantic Differences in Management of Carotid Stenosis: BRIDGing the Gap in StrokE Management (BRIDGE) ProjectClotilde Balucani, Vanessa Arnedo, Jeremy Weedon, et al.
JACC. Cardiovascular Interventions|October 25, 2014
Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot studyJosep Rodés-Cabau, Philip Kahlert, Franz-Josef Neumann, et al.
Pageof 2